SG Americas Securities, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$226
-99.9%
7,971
-12.7%
0.00%0.0%
Q3 2022$241,000
-41.1%
9,133
-0.7%
0.00%
-25.0%
Q2 2022$409,000
-66.5%
9,202
-62.7%
0.00%
-55.6%
Q1 2022$1,222,000
+15.4%
24,698
+18.8%
0.01%
+50.0%
Q4 2021$1,059,000
-64.1%
20,793
-60.7%
0.01%
-57.1%
Q3 2021$2,950,000
+46.1%
52,888
+12.1%
0.01%
+55.6%
Q2 2021$2,019,000
-13.7%
47,165
-15.9%
0.01%
-25.0%
Q1 2021$2,340,000
-16.4%
56,071
-6.7%
0.01%
-20.0%
Q4 2020$2,799,000
+187.1%
60,103
+162.0%
0.02%
+150.0%
Q3 2020$975,000
-64.0%
22,941
-59.3%
0.01%
-73.9%
Q2 2020$2,707,000
+62.4%
56,429
+55.7%
0.02%
+43.8%
Q1 2020$1,667,000
+31.0%
36,236
+71.0%
0.02%
+33.3%
Q4 2019$1,273,000
+163.0%
21,189
+147.8%
0.01%
+200.0%
Q3 2019$484,000
+281.1%
8,550
+241.0%
0.00%
+300.0%
Q1 2019$127,000
-59.6%
2,507
-67.8%
0.00%
-66.7%
Q4 2018$314,000
-41.1%
7,795
+10.6%
0.00%
-40.0%
Q2 2018$533,000
-8.3%
7,046
-36.1%
0.01%0.0%
Q1 2018$581,000
+47.1%
11,035
+49.4%
0.01%
+25.0%
Q4 2017$395,000
+46.8%
7,385
+63.7%
0.00%
+100.0%
Q3 2017$269,000
+21.7%
4,511
+60.8%
0.00%0.0%
Q2 2017$221,000
-12.0%
2,805
-7.2%
0.00%0.0%
Q1 2017$251,000
-53.2%
3,022
-55.3%
0.00%
-50.0%
Q4 2016$536,000
+222.9%
6,760
+184.6%
0.00%
+100.0%
Q3 2016$166,000
+14.5%
2,375
+21.6%
0.00%
+100.0%
Q3 2015$145,0001,9530.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders